A collaboration among Indiana universities that helps translate research in the lab into patient treatments has awarded $750,000
to 10 teams of researchers.
The Indiana Clinical and Translational Sciences Institute was funded in 2008 through a $25 million grant from the National Institutes of Health.
Among research funded in the latest round was $75,000 to a Purdue University team headed by Graham Cooks developing a way to monitor prostate cancer using cholesterol sulfate in biofluids.
A team led by Melissa Kacena at the Indiana University School of Medicine landed a grant to further research healing long-bone-segment defects. University of Notre Dame researchers also received funding.
The awards go toward early-stage research that build collaborations within the three partner universities.
“These projects are expected to test novel ideas which lead to the development of new treatments or products, and would also be expected to generate significant grants and investments from external sources,” said Anantha Shekhar, director of CTSI.
A previous round of grants resulted in more than two dozen new grant applications, according to CTSI.
The CTSI “is the perfect example” of efforts to tie various university assets together to advance life sciences in Indiana, Tony Armstrong, president and CEO of the IU Research and Technology Corp., told the audience at IBJ’s July 23 Life Sciences Power Breakfast.